Rhenman & Partners Asset Management’s GoodRx Holdings GDRX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-235,000	Closed	-$4.54M	–	90
2022 Q1	$4.54M	Buy	+235,000	New	+$5.39M	0.45%	65
2021 Q2	–	Sell	-75,000	Closed	-$2.93M	–	97
2021 Q1	$2.93M	Buy	75,000 +40,000	+114%	+$1.8M	0.2%	87
2020 Q4	$1.41M	Buy	+35,000	New	+$1.61M	0.12%	81

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Rhenman & Partners Asset Management's GDRX Position: Q2 2022 in Review

Rhenman & Partners Asset Management sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 235,000 shares — an estimated $4.54M sold.

Rhenman & Partners Asset Management first reported a position in GDRX in Q4 2020 and held it in 3 quarters. The position peaked at $4.54M in Q1 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

Rhenman & Partners Asset Management reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
Rhenman & Partners Asset Management sold 235,000 GoodRx Holdings shares in Q2 2022, an estimated $4.54M.
Rhenman & Partners Asset Management first reported a position in GoodRx Holdings in Q4 2020 and held it in 3 quarters.
Rhenman & Partners Asset Management's GoodRx Holdings position peaked at $4.54M in Q1 2022.
174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.